SAR443122
Total Payments
$13,155
Transactions
18
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $13,155 | 18 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,814 | 6 | 89.8% |
| Travel and Lodging | $1,145 | 9 | 8.7% |
| Food and Beverage | $195.30 | 3 | 1.5% |
Top Doctors Receiving Payments for SAR443122
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Internal Medicine | Boston, MA | $13,155 | 18 |
Ad
Manufacturing Companies
- SANOFI-AVENTIS U.S. LLC $13,155
Product Information
- Type Drug
- Total Payments $13,155
- Total Doctors 1
- Transactions 18
About SAR443122
SAR443122 is a drug associated with $13,155 in payments to 1 healthcare providers, recorded across 18 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI-AVENTIS U.S. LLC.
Payment data is available from 2019 to 2019. In 2019, $13,155 was paid across 18 transactions to 1 doctors.
The most common payment nature for SAR443122 is "Consulting Fee" ($11,814, 89.8% of total).